Intelligent OMICS

Intelligent OMICS is a biotechnology company applying artificial intelligence and machine learning to drug discovery and diagnostics.

Its proprietary platform analyses transcriptomic, genomic, and proteomic datasets to identify novel biological targets and disease drivers.

The company offers fee-for-service target identification and biomarker panel development to pharmaceutical partners, and advances its own drug candidates, including small molecule programmes in lung cancer.